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the exact tissue type of each sample, 
only  that  tonsils,  adenoids,  or  both 
combined could be present, the 5.5% 
rate we found was about one third the 
rate found in tonsil lymphocytes and 
about one tenth the rate found in ad-
enoid lymphocytes.
A seasonal effect may contribute to 
the large discrepancies found in HBoV 
prevalences.  Apparently,  viruses  can 
persist in tonsillar tissue well after the 
symptomatic phase of illness. In chil-
dren with no signs of acute respiratory 
infection, Drago et al. (7) reported that 
45.5% of samples contained viral nu-
cleic acid. Depending on the duration 
of persistence, asymptomatic children, 
sampled shortly after the season of the 
virus in question, would be more likely 
to have detectable virus in their tonsillar 
tissue. The Longtin et al. study samples 
were collected from December through 
April; our study samples were collected 
from June through September. If HBoV 
is seasonal, as has been suggested (3), it 
may have been circulating in the target 
population before samples were taken 
and persisted only in tonsillar tissues. 
Thus,  if  tonsillar  tissue  from  asymp-
tomatic children was obtained within 
the persistence period after the HBoV 
season, samples would be HBoV posi-
tive;  those  obtained  shortly  after  the 
persistence period would have a much 
lower rate.
Differences in patient age in the 
3 studies may also have contributed 
to  the  different  rates  observed.  The 
Longtin et al. group was substantial-
ly  younger  (median  age  23  months) 
than the Lu et al. group (median age 
5 years) or our group (median age 5.9 
years). Preliminary seroepidemiology 
reports indicate the presence of HBoV 
antibodies  in  >50%  of  children  2–3 
years of age (8,9).
The  detection  of  HBoV  in  the 
tonsillar  tissues  we  tested  showed  a 
higher rate of infection than would be 
expected in an asymptomatic popula-
tion. However, the rate was far lower 
than that previously reported for ton-
sillar tissues (1,4).  
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Bartonella  
rochalimae and 
Other Bartonella 
spp. in Fleas, Chile
To the Editor: Fleas are involved 
in the natural cycle of different Barto-
nella spp. Among the 20 currently rec-
ognized Bartonella spp., 13 species or 
subspecies have been implicated in hu-
man disease. Recently, B. rochalimae 
was identified in a patient who had re-
ceived numerous insect bites and sub-
sequently had bacteremia, fever, and 
splenomegaly after visiting Peru (1). 
A  recent  study  in  Taiwan  suggested 
that rodents could be a reservoir for B. 
rochalimae (2), but the vector or other 
mechanism  of  infection  remains  un-
known. We amplified B. rochalimae, 
B. clarridgeiae, and B. henselae from 
fleas (Pulex irritans and Ctenocepha-
lides felis) collected in Chile and dis-
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cuss the role of these fleas as possible 
vectors of infection.
From 2005 through 2008, we col-
lected 82 fleas from cats and dogs in 
pounds in Chile: 34 P. irritans, 37 C. 
felis, and 11 C. canis. Fleas were kept 
in 70% ethanol and sent to the Special 
Pathogens Laboratory of the Área de 
Enfermedades Infecciosas of the Hos-
pital San Pedro, La Rioja, Spain, to be 
examined  for  Bartonella  spp.  Fleas 
were then rinsed in distilled water and 
dried on sterile filter paper under a lam-
inar-flow hood. Each flea was crushed 
with  a  sterile  pestle,  and  DNA  was 
extracted by lysis with 0.7 M ammo-
nium hydroxide. PCR was used to de-
tect Bartonella DNA (according to the 
defining criteria for Bartonella spp.); 
primers targeted the RNA polymerase 
β-subunit–encoding gene (rpoB) and 
the citrate synthase gene (gltA) (3–5). 
PCR  primers  for  a  fragment  of  the 
16/23S  rRNA  intergenic  region  and 
the heat-shock protein-encoding gene 
(groEL) were also used (6,7). Positive 
controls (B. henselae strain Marseille, 
kindly supplied by Unité des Rickett-
sies, Faculté de Médecine, Université 
de la Méditerranée, Marseille, France) 
and  negative  controls  (sterile  water 
instead of template DNA) were used. 
PCR products were purified, and both 
strands of each amplicon were subject-
ed  to  sequence  analysis.  Nucleotide 
sequence  homologies  were  searched 
by using BLAST (www.ncbi.nlm.nih.
gov/blast/Blast.cgi).
When  rpoB  primers  were  used, 
Bartonella spp. were found in 4 C. felis 
(4.8%) fleas from cats and in 4 P. irri-
tans (4.8%) fleas from dogs. The same 
8 samples were positive when prim-
ers  for  gltA  gene  and  16/23S  rRNA 
intergenic region were used. Unfortu-
nately, none of the 82 specimens were 
positive when PCR primers targeting 
the groEL gene were used. In all ex-
periments, negative controls remained 
negative.
Sequencing  of  the  825-bp  rpoB 
fragments  from  the  4  C.  felis  fleas 
indicated that they were most closely 
aligned with the gene sequences of B. 
clarridgeiae (n = 2, >99% similarity) 
and B. henselae (n = 2, 100% similar-
ity). Using gltA (380 bp), we found 
100% similarity with B. clarridgeiae 
and  B.  henselae.  Accordingly,  the 
16/23S  rRNA  amplicons  from  these 
specimens exhibited 100% similarity 
with the corresponding sequences of 
B. clarridgeiae (154 bp) and B. hense-
lae (172 bp).
Amplicons  for  the  rpoB  frag-
ment  gene  obtained  from  4  P.  irri-
tans  fleas  showed  highest  similar-
ity  (97.2%–99.5%)  with  rpoB  of  B. 
rochalimae. Three were identical, and 
we deposited the consensus sequence 
in GenBank in 2006 under the name 
“uncultured  Bartonella  sp.”  and  ac-
cession no. DQ858956. The sequence 
differed from those described for all 
known Bartonella spp. and phyloge-
netically was most closely related to 
B. clarridgeiae (8). The sequence of 
the protein encoded by rpoB in these 
3 specimens (protein_id ABH09235) 
had 3 aa changes (121I→V, 233K→I, 
and 274N→E) with respect to the de-
duced sequence of the RpoB protein 
for B. rochalimae. The importance of 
these changes remains unknown. The 
remaining  nucleotide  sequence  was 
recently submitted to GenBank under 
accession  no.  FJ147196,  designated 
B.  rochalimae  because  isolation  of 
this new Bartonella spp. was reported 
in 2007 (1). These 4 specimens also 
yielded positive PCR products for gltA 
(380 bp) and 16/23S rRNA (≈175 bp). 
Subsequent nucleotide sequence anal-
ysis showed 100% homology with the 
corresponding  partial  nucleotide  se-
quences from B. rochalimae.
In 2002, Parola et al. (9) amplified 
Bartonella DNA by using PCR with 
Pulex spp. fleas collected from persons 
in Peru and suggested the existence of 
a new Bartonella sp. The nucleotide 
sequence  of  the  16S-23S  ribosomal 
RNA intergenic spacer obtained from 
1 genotype (clone F17688) was nearly 
identical  to  the  corresponding  se-
quence of B. rochalimae. This finding 
suggests that Pulex spp. fleas could be 
vectors.
Cat  scratch  disease  has  been 
reported  in  Chile,  and  B.  henselae 
has been found in cats in Chile (10). 
Thus, our finding of B. henselae and 
B. clarridgeiae in C. felis fleas from 
Chile confirms the risk for exposure 
of humans in contact with cat fleas. 
Furthermore, our finding of B. roch-
alimae in P. irritans fleas from dogs 
in Chile supports the possibility that 
P. irritans fleas could be vectors for 
B. rochalimae. These findings are of 
public health importance because they 
identify possible vectors of these hu-
man pathogens.
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